Pustular eruption at the site of subcutaneous injection of recombinant human granulocyte-macrophage colony-stimulating factor.
Passweg
J
J
Department of Internal Medicine, Kantonsspital Basel, Switzerland.
Buser
U
U
Tichelli
A
A
Gratwohl
A
A
Speck
B
B
D000328:Adult; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000627:therapeutic use; D003875:Drug Eruptions / Q000473:pathology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy; D011994:Recombinant Proteins; D013492:Suppuration; D014182:Transplantation, Autologous
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003520:Cyclophosphamide; D008558:Melphalan